KRAS and colorectal cancer: Unlike other types of cancer, with the exception of KRAS mutation, few of the studied markers have entered the clinical management of colorectal cancer so far, due to inconclusive studies or lack of current clinical applicability although they are widespread available in molecular biology laboratories [10].